Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevention of Retinal Non-perfusion in Central Retinal Vein Occlusion by Hydroxycarbamide Treatment.

NCT02957760 is registered in ClinicalTrials.gov with Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts as lead sponsor.

NCT NCT02957760
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02957760 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevention of Retinal Non-perfusion in Central Retinal Vein Occlusion by Hydroxycarbamide Treatment.
Lead sponsor
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
Phase
Phase 2
Overall status
Unknown status
Start date
December 31, 2015
Completion date
December 31, 2017
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

central retinal vein occlusion, non-ischemic